Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment.
The American journal of psychiatry 2025 Sharmin Ghaznavi, Jeremy N Ruskin, Stephen J Haggerty et al.
The last few years have seen exponential growth in interest, investment, advocacy, and research into psychedelics as therapeutics. This reflects an optimism about the potential promise of psychedelics as therapeutics. As with all therapeutic interventions, research is needed not only into their benefits but also potential risks. Indeed, when substances with therapeutic potential are scrutinized...